Dokter Hacquaert
ActiveSummary
Dokter Hacquaert has been active since 1994 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €584k and a net result of €23k. Equity is growing by ~12.3% per year across the filed fiscal years. Its solvency ranks better than 89% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
90
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability73▼-27
Solvency100=
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €50k at 30 days acceptable
Liquidity ample (current ratio 16.64 against 29.44 in 2024; short-term debt: 5.6% and cash: 28.4% of total assets), and 6.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
93.6%
Return on assets
3.8%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
24 d early
2024
3 d early
2023
65 d early
2022
31 d late
2021
34 d early
2020
61 d late
2019
4 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€584k▲ 1.6%
2024 · €575k
2019: €321k
2020: €366k
2021: €284k
2022: €321k
2023: €354k
2024: €575k
2019 → 2025
Total assets
€624k▲ 4.1%
2024 · €599k
2019: €512k
2020: €436k
2021: €403k
2022: €390k
2023: €413k
2024: €599k
2019 → 2025
Net result
€23k▼ 89.4%
2024 · €222k
2019: €60k
2020: €45k
2021: €3k
2022: €37k
2023: €33k
2024: €222k
2019 → 2025
Working capital
€542k▲ 0.2%
2024 · €541k
2019: €-24k
2020: €24k
2021: €-22k
2022: €56k
2023: €123k
2024: €541k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€284k-€321k▲ 12.9%€354k▲ 10.3%€575k▲ 62.6%€584k▲ 1.6%
Operating result€19k-€60k▲ 207%€52k▼ 12.5%€324k▲ 521%€25k▼ 92.4%
Net result€3k-€37k▲ 1,295%€33k▼ 9.7%€222k▲ 569%€23k▼ 89.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 92% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €624k
Fixed assets
€48k ▲ 21.2%
Current assets
€576k ▲ 2.9%
Equity and liabilities €624k
Equity
€584k ▲ 1.6%
Debt
€40k ▲ 66.1%
Debt's share of the balance-sheet total rises from 4.0% to 6.4%. Equity and debt are higher.
Key figures and ratios
EBITDA
€30k▼
2024 · €330k
Cash flow
€29k▼
2024 · €227k
Current ratio
16.64▼
2024 · 29.44
Debt to equity
0.07▲
2024 · 0.04
ROE
4.0%▼
2024 · 38.5%
ROA
3.8%▼
2024 · 37.0%
Interest coverage
305.52▼
2024 · 3379.78
Debt ≤ 1 year
€35k▲
2024 · €19k
Income taxes
€13k▼
2024 · €105k
Staff costs
€32k▲
2024 · €27k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet
Code20242025
Assets
Total assets20/58€599k€624k▲
Fixed assets21/28€39k€48k▲
Tangible fixed assets22/27€39k€47k▲
Land and buildings22€0-
Furniture and vehicles24€0-
Other tangible fixed assets26€39k€47k▲
Financial fixed assets28€272€272=
Current assets29/58€560k€576k▲
Amounts receivable after more than one year29€473k€8k▼
Other amounts receivable291€473k€8k▼
Amounts receivable within one year40/41€25k€23k▼
Other amounts receivable41€25k€23k▼
Current investments50/53-€340k
Cash at bank and in hand54/58€45k€177k▲
Deferred charges and accrued income490/1€17k€28k▲
Equity and liabilities
Total equity and liabilities10/49€599k€624k▲
Equity10/15€575k€584k▲
Contributions10/11€19k€19k=
Reserves13€557k€566k▲
Distributable reserves133€557k€566k▲
Profit (loss) carried forward14-€0
Amounts payable17/49€24k€40k▲
Amounts payable within one year42/48€19k€35k▲
Trade debts44€3k€2k▼
Suppliers440/4€3k€2k▼
Taxes, remuneration and social security45€13k€18k▲
Taxes450/3€6k€13k▲
Remuneration and social security454/9€7k€5k▼
Other amounts payable47/48€3k€14k▲
Accrued charges and deferred income492/3€5k€5k▲
Income statement
Code20242025
Non-recurring operating income76A€268k€0▼
Remuneration, social security and pensions62€27k€32k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6k€6k▼
Other operating charges640/8€10k€7k▼
Gross operating margin9900€366k€69k▼
Operating profit (loss)9901€324k€25k▼
Financial income75/76B€3k€12k▲
Recurring financial income75€3k€12k▲
Financial charges65/66B€98€99▲
Recurring financial charges65€98€99▲
Profit (loss) for the period before taxes9903€327k€37k▼
Income taxes67/77€105k€13k▼
Profit (loss) for the period9904€222k€23k▼
Profit (loss) for the period to be appropriated9905€222k€23k▼
Appropriation of the result
Profit (loss) to be appropriated9906€222k€23k▼
Transfer from equity791/2-€14k
Transfer to equity691/2€222k€23k▼
To other reserves6921€222k€23k▼
Profit to be distributed694/7-€14k
Return on contributions (dividend)694-€14k
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
07-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
28-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2019net €222k ▲569%
Operating result €324k, net result €222k, both a record.
31-12
Financial
Liquidity times 9current ratio 29.44
Current ratio from 3.24 to 29.44; short-term debt falls from €55k to €19k.
31-12
Financial
Equity above €500kEq €575k ▲62.6%
6 profitable years in a row build equity to €575k.
27-05
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-12
Financial
Liquidity doublescurrent ratio 1.88
Current ratio from 0.80 to 1.88; short-term debt falls from €114k to €64k.
27-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Weakest financial yearnet €3k ▼94.1%
Net result drops to €3k, the lowest in the series; recovery starts the following year.
30-09
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 61 days late
2020
27-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Show earlier events
2019
31-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
31-01
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2016
22-12
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Niklaas · 1 establishment unit since 1994
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Zamanstraat 359100 Sint-NiklaasGround area
269 m²
Building footprint
197 m²
Volume, LiDAR
1,655 m³
Parcel 46443E0222/00G000, Flanders · tallest building 16.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Zamanstraat 35, 9100 Sint-Niklaas
since 19942.230.575.376
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 46443E0222/00G000 | Flanders | 269 m² | 1 · 197 m² | 16.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
CENTRE DE RADIOLOGIE DE FLEURUS
BE 0430.496.985
Fleurus · Eq €586,677
BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL
BE 0475.471.036
Gent · Eq €586,742
DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE
BE 0439.896.582
Pajottegem · Eq €587,355
Biocytom GBX
BE 0543.497.928
Gembloux · Eq €587,744
CELL-CELL BIO
BE 0782.638.362
Gent · Eq €588,405
Of 698 companies in sector 86910 we hold annual accounts for 520. 404 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-03-1994
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 31 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.